Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Update

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 52,162 shares, a growth of 326.1% from the June 30th total of 12,241 shares. Approximately 1.4% of the shares of the stock are sold short. Based on an average daily volume of 76,346 shares, the short-interest ratio is currently 0.7 days.

Invesco Pharmaceuticals ETF Stock Up 0.1%

NYSEARCA PJP opened at $120.37 on Friday. Invesco Pharmaceuticals ETF has a twelve month low of $80.63 and a twelve month high of $122.69. The business has a 50-day moving average price of $114.20 and a 200-day moving average price of $108.55. The firm has a market cap of $438.15 million, a price-to-earnings ratio of 15.59 and a beta of 0.45.

Institutional Investors Weigh In On Invesco Pharmaceuticals ETF

Several institutional investors and hedge funds have recently modified their holdings of PJP. Bank of America Corp DE lifted its holdings in shares of Invesco Pharmaceuticals ETF by 234.0% in the first quarter. Bank of America Corp DE now owns 74,458 shares of the company’s stock worth $7,726,000 after buying an additional 52,165 shares in the last quarter. Royal Bank of Canada grew its stake in Invesco Pharmaceuticals ETF by 479.8% during the first quarter. Royal Bank of Canada now owns 62,377 shares of the company’s stock valued at $6,472,000 after acquiring an additional 51,619 shares in the last quarter. LPL Financial LLC grew its stake in Invesco Pharmaceuticals ETF by 5.6% during the fourth quarter. LPL Financial LLC now owns 59,366 shares of the company’s stock valued at $6,206,000 after acquiring an additional 3,156 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Invesco Pharmaceuticals ETF by 96.8% during the fourth quarter. Wells Fargo & Company MN now owns 37,772 shares of the company’s stock valued at $3,949,000 after purchasing an additional 18,576 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its position in shares of Invesco Pharmaceuticals ETF by 829.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 25,941 shares of the company’s stock valued at $2,712,000 after purchasing an additional 23,150 shares in the last quarter.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.